Development
Gilead Sciences, Inc.
GILD
$112.46
-$2.05-1.79%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -34.48% | 108.71% | 3.47% | -38.41% | -8.33% |
| Total Depreciation and Amortization | 0.58% | 0.44% | 6.41% | 21.21% | 0.57% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 35.54% | 56.23% | -55.82% | 125.53% | -57.66% |
| Change in Net Operating Assets | 64.95% | -567.98% | 161.07% | -563.25% | 200.00% |
| Cash from Operations | 23.59% | -24.94% | 34.06% | -32.06% | -10.34% |
| Capital Expenditure | -76.23% | 12.23% | -27.52% | 39.78% | -15.29% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -253.16% | 67.49% | 55.90% | -152.75% | 51.34% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -732.14% | 72.28% | 39.16% | -791.67% | 122.22% |
| Cash from Investing | -217.47% | 52.59% | 41.53% | -120.27% | 47.41% |
| Total Debt Issued | -99.95% | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | -- | -- | -- | 100.00% |
| Issuance of Common Stock | -68.67% | 219.23% | -73.20% | -44.89% | 388.89% |
| Repurchase of Common Stock | 50.00% | -100.00% | 62.50% | 49.49% | -340.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 1.05% | -0.95% | 2.58% | -5.90% | 1.51% |
| Other Financing Activities | 57.69% | -136.36% | 75.37% | -482.61% | 48.89% |
| Cash from Financing | 27.65% | -37.97% | 21.69% | 9.52% | 26.63% |
| Foreign Exchange rate Adjustments | 716.67% | -146.15% | 0.00% | -82.67% | 204.17% |
| Miscellaneous Cash Flow Adjustments | -- | -- | 200.00% | -- | -- |
| Net Change in Cash | 37,900.00% | -99.87% | 261.34% | -166.76% | 1,882.50% |